Blue Granite Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-8,022
Closed -$1.52M 119
2017
Q3
$1.52M Sell
8,022
-6,478
-45% -$1.23M 1.05% 41
2017
Q2
$2.73M Sell
14,500
-2,500
-15% -$449K 1.77% 25
2017
Q1
$2.81M Hold
17,000
1.84% 24
2016
Q4
$2.44M Buy
+17,000
New +$2.28M 1.74% 24

Other funds holding ELV

Blue Granite Capital's ELV Position: Q4 2017 in Review

Blue Granite Capital sold out of Elevance Health (ELV) in Q4 2017, closing a stake of 8,022 shares — an estimated $1.52M sold.

Blue Granite Capital first reported a position in ELV in Q4 2016 and held it in 4 quarters. The position peaked at $2.81M in Q1 2017. 909 funds tracked by Wall St. Rank hold ELV as of Q4 2017.

  • Blue Granite Capital reported no remaining Elevance Health position as of Q4 2017 after selling out during the quarter.
  • Blue Granite Capital sold 8,022 Elevance Health shares in Q4 2017, an estimated $1.52M.
  • Blue Granite Capital first reported a position in Elevance Health in Q4 2016 and held it in 4 quarters.
  • Blue Granite Capital's Elevance Health position peaked at $2.81M in Q1 2017.
  • 909 funds tracked by Wall St. Rank held Elevance Health as of Q4 2017.

Based on Blue Granite Capital's 13F filing for Q4 2017, filed 14 Feb 2018.